Join the Breakthrough Pain group to help and get support from people like you.
Breakthrough Pain News
Related terms: Pain, breakthrough
FDA Warns of Rising Injuries From Misuse of Laughing Gas
MONDAY, March 17, 2025 – Health officials are warning about a rise in injuries linked to the misuse of nitrous oxide, aka laughing gas. The gas, which is used medically as a sedative and in whipped...
Guidance Provided for Safe Use of Ketamine
TUESDAY, Feb. 25, 2025 – Administration of ketamine for purposes other than acute pain management and procedural sedation should be subject to the same prescribing guidelines as other sedating...
FDA Approves Journavx, First New Non-Opioid Pain Pill in Decades
FRIDAY, Jan. 31, 2025 – The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin....
Reiki May Help Ease the Pain of Cancer Treatment
FRIDAY, Dec. 13, 2024 – The ancient Japanese practice of reiki "energy healing" might help some cancer patients deal with the pain that can come with infusion therapies, new research shows....
Women Get Worse Pain Management, From Both Male and Female Health Workers
TUESDAY, Aug. 13, 2024 – Female patients are consistently less likely to receive painkillers than men with similar complaints, a new study finds. An analysis of more than 21,000 patient records...
FDA Approves Lazanda - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients
READING, England and BEDMINSTER, N.J., June 30, 2011 /PRNewswire/ – Archimedes Pharma Ltd., and its subsidiary, Archimedes Pharma U.S. Inc., today announced that the U.S. Food and Drug...
FDA Approval for Abstral (Fentanyl) Sublingual Tablets
Uppsala, January 10, 2011 - Orexo AB announces today that its partner ProStrakan Group plc has received approval from the US Food and Drug Administration (FDA) for Abstral. Abstral is licensed for...